About CTL

We Introduced the Current Cytokine ELISPOT Protocols

A new generation of ELISPOT assays was introduced and patented at Case Western Reserve University (CWRU) by a network of collaborating scholars led by Paul V. Lehmann, M.D., Ph.D., Professor of Pathology. The original ELISPOT protocols were established to detect antibody-producing B cells. Because T cells produce much less cytokine than B cells produce antibodies, our improved protocols have been critical for cytokine ELISPOT assays' robust performance. more....